BridgeBio Pharma BBIO Ratios (2018-2026)

NASDAQ BBIO
$74.84 -0.57 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

BridgeBio Pharma Quarterly Ratios

Periods 33 quarters
Latest Jun 2026

BridgeBio Pharma reported a gross margin of 93.83% and a net margin of -62.47% for the quarter ended Jun 2026. These financial ratios cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
37.97%84.49%20.43%99.05%-118.64%65.40%64.35%63.50%85.38%65.73%99.72%72.42%78.11%64.57%97.74%96.70%94.56%94.74%94.89%93.83%
EBT Margin
-6,840.10%-1,805.66%-11,468.30%-136.28%-43,350.30%-7,760.96%-7,993.87%-10,153.44%-4,258.25%-11,008.94%-10.97%-3,484.50%-6,012.23%-4,526.28%-105.03%-164.30%-154.50%-126.32%-61.14%-63.97%
EBIT Margin
-6,377.94%-1,656.14%-10,252.54%-108.72%-38,200.00%-6,910.80%-6,909.26%-8,903.05%-3,854.61%-10,167.11%0.16%-8,096.82%-7,018.67%-3,842.69%-89.49%-121.45%-120.30%-90.52%-54.47%-43.94%
EBITDA Margin
-6,377.94%-1,656.14%-10,252.54%-108.72%-38,200.00%-6,910.80%-6,909.26%-8,903.05%-3,854.61%-10,167.11%0.16%-8,096.82%-7,018.67%-3,842.69%-89.49%-121.45%-120.30%-90.52%-54.47%-43.94%
Operating Margin
-6,377.94%-1,656.14%-10,252.54%-108.72%-38,200.00%-6,910.80%-6,909.26%-8,903.05%-3,854.61%-10,167.11%0.16%-8,096.82%-7,018.67%-3,842.69%-89.49%-121.45%-120.30%-90.52%-54.47%-43.94%
Net Margin
-6,652.52%-1,471.77%-11,593.68%-13.36%-40,632.84%-7,357.81%-7,675.58%-9,622.12%-4,326.55%-9,635.99%-16.68%-3,388.19%-5,931.19%-4,506.12%-143.55%-164.52%-151.40%-125.09%-84.33%-62.47%
FCF Margin
-5,461.73%-1,364.31%-9,533.29%-44.55%-40,213.61%-5,029.09%-7,908.98%-6,928.52%-3,560.43%-7,177.88%-104.32%3,443.22%-6,614.31%-3,321.54%-171.11%-73.20%-91.17%-36.62%-101.46%-29.36%
Efficiency
Inventory AverageInventory Avg.
0.01B0.02B0.03B0.03B0.04B
Assets AverageAssets Avg.
0.93B0.90B0.91B0.84B0.80B0.68B0.62B0.56B0.58B0.60B0.70B0.82B0.73B0.79B0.90B0.98B1.04B0.97B1.15B1.29B
Invested CapitalInvested Cap.
-0.64B-0.44B-0.61B-0.60B-0.71B-0.81B-0.78B-0.91B-0.75B-0.90B-0.60B-0.65B-0.78B-1.02B-1.64B-1.78B0.07B-0.08B0.93B0.69B
Asset Utilization RatioAsset Util.
0.060.070.070.100.110.110.120.010.020.020.310.270.300.280.140.240.340.520.500.55
Leverage & Solvency
Interest Coverage RatioInterest Cover
-13.51-10.94-8.54-3.95-6.51-6.46-6.27-7.09-7.77-8.750.01-7.65-8.31-10.50-5.76-11.57-12.37-11.99-8.19-8.06
Debt Ratio
0.130.430.530.490.580.690.700.870.670.820.510.550.660.482.012.142.332.63
Times Interest Earned
-13.51-10.94-8.54-3.95-6.51-6.46-6.27-7.09-7.77-8.750.01-7.65-8.31-10.50-5.76-11.57-12.37-11.99-8.19-8.06
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
FCF Payout RatioFCF Cover
Dividend YieldDiv. Yield
Payout Ratio
Valuation
Price to EarningsP/E
-44.21-16.70-7.63-136.57-10.81-8.34-18.98-17.58-25.94-42.03-164.30-64.84-29.69-19.67-39.20-45.38-54.75-77.25-88.59-95.55
Price to SalesP/S
0.00B245.77884.9118.250.00B613.780.00B0.00B0.00B0.00B27.410.00B0.00B886.5756.2674.6682.8996.6374.7259.69
Price to BookP/B
-9.33-2.83-1.44-1.33-1.32-0.92-2.19-2.06-3.84-5.26-5.58-4.40-3.95-3.58-4.01-4.64-5.18-7.14-6.41-5.78
Enterprise Value
6.30B2.07B0.87B0.67B0.94B0.74B2.22B2.44B4.06B6.64B5.28B4.23B4.42B4.54B6.03B7.51B9.37B14.32B13.60B13.83B
EV to EBIT
-42.13-12.48-4.99-8.35-7.26-5.76-17.56-16.67-25.75-37.450.00B-24.08-23.03-20.10-57.79-55.91-64.53-102.62-128.39-129.20
EV to EBITDA
-42.13-12.48-4.99-8.35-7.26-5.76-17.56-16.67-25.75-37.450.00B-24.08-23.03-20.10-57.79-55.91-64.53-102.62-128.39-129.20
Market Capitalization
6.89B2.46B1.50B1.35B1.48B1.15B2.66B2.78B4.59B7.07B5.79B4.76B4.81B5.21B6.56B8.25B10.01B14.90B14.53B14.54B
Price to FCFP/FCF
-53.85-18.01-9.28-40.97-10.92-12.20-18.42-24.42-31.53-56.43-26.2763.80-26.63-26.69-32.88-101.98-90.92-263.90-73.64-203.30
EV to FCF
-49.20-15.15-5.36-20.38-6.89-7.92-15.34-21.42-27.88-53.05-23.9756.62-24.44-23.26-30.22-92.75-85.15-253.68-68.93-193.38
EV to CFO
-51.82-15.44-5.39-21.98-6.93-7.98-15.35-21.49-27.96-53.23-24.0456.58-24.46-23.26-30.27-93.05-85.51-253.83-68.96-194.58
Return Ratios
Return on Sales [ROS]ROS
-6,377.94%-1,656.14%-10,252.54%-108.72%-38,200.00%-6,910.80%-6,909.26%-8,903.05%-3,854.61%-10,167.11%0.16%-8,096.82%-7,018.67%-3,842.69%-89.49%-121.45%-120.30%-90.52%-54.47%-43.94%
Return on Capital Employed [ROCE]ROCE
-64.44%-75.66%-72.00%-81.69%-81.12%-92.38%-88.05%-116.73%-118.15%-132.95%-86.43%-74.23%-92.19%-92.98%-93.23%-81.54%-74.14%-77.07%-155.72%-123.37%
Return on Invested Capital [ROIC]ROIC
38.60%71.76%20,958.42%-61.57%
Return on Assets [ROA]ROA
-62.33%-69.46%-70.09%-75.88%-78.17%-86.76%-86.19%-107.01%-109.08%-113.02%-79.68%-56.58%-62.36%-66.95%-69.93%-75.23%-73.00%-70.91%-59.14%-50.56%